Skip to main content
  • Saved

made a Post

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting - PubMed

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/32802465/

In advanced stage non-small cell lung cancer (NSCLC) patients, Kirsten Rat Sarcoma Viral Oncogene Homolog ( KRAS ) testing may soon acquire a predictive significance to select patients for AMG510 treatment. Since tissue samples are not always available, liquid biopsy may represent a viable opti ...